Vidiia

Vidiia is a diagnostics company developing AI-powered, portable molecular testing devices for point-of-care and field-based disease detection.

Its platform combines RT-LAMP assay chemistry with smartphone-connected artificial intelligence to interpret results, and has received UK regulatory approval for medical use.

Originating from a collaboration between the University of Surrey, Lancaster University and Brunel University London, Vidiia now runs an Assay Accelerator programme translating academic diagnostic research into deployable, low-cost testing tools.